George Kaiser Family Foundation’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$401K Hold
815
0.05% 46
2025
Q4
$472K Hold
815
0.06% 34
2025
Q3
$395K Hold
815
0.06% 58
2025
Q2
$330K Buy
815
+302
+59% +$126K 0.05% 67
2025
Q1
$255K Buy
+513
New +$278K 0.04% 63
2023
Q4
Sell
-4,740
Closed -$2.4M 38
2023
Q3
$2.4M Hold
4,740
0.45% 24
2023
Q2
$2.47M Sell
4,740
-902
-16% -$487K 0.42% 27
2023
Q1
$3.25M Hold
5,642
0.52% 20
2022
Q4
$3.11M Buy
5,642
+965
+21% +$511K 0.46% 17
2022
Q3
$2.37M Buy
4,677
+468
+11% +$262K 0.42% 19
2022
Q2
$2.29M Hold
4,209
0.41% 23
2022
Q1
$2.49M Hold
4,209
0.41% 26
2021
Q4
$2.81M Hold
4,209
0.4% 23
2021
Q3
$2.4M Hold
4,209
0.4% 27
2021
Q2
$2.12M Buy
+4,209
New +$1.99M 0.34% 30

Other funds holding TMO

George Kaiser Family Foundation's TMO Position: Q1 2026 in Review

George Kaiser Family Foundation held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 815 shares worth $401K. The position accounts for 0.05% of the portfolio, ranked #46.

George Kaiser Family Foundation first reported a position in TMO in Q2 2021 and has held it in 15 quarters since. The position peaked at $3.25M in Q1 2023. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • George Kaiser Family Foundation held 815 shares of Thermo Fisher Scientific worth $401K as of Q1 2026.
  • George Kaiser Family Foundation left its Thermo Fisher Scientific share count unchanged in Q1 2026.
  • Thermo Fisher Scientific made up 0.05% of George Kaiser Family Foundation's portfolio in Q1 2026, its #46 holding.
  • George Kaiser Family Foundation first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 15 quarters since.
  • George Kaiser Family Foundation's Thermo Fisher Scientific position peaked at $3.25M in Q1 2023.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on George Kaiser Family Foundation's 13F filing for Q1 2026, filed 14 May 2026.